Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis

Clinical and Vaccine Immunology

Volumn 19, Issue 8, 2012, Pages 1326-1328

  L'Ollivier, Coralie ^a   Wallon, Martine ^b   Faucher, Benoit ^a   Piarroux, Renaud ^a   Peyron, François ^b   Franck, Jacqueline ^a  

^a TIMONE HOSPITAL   (France)

^b CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATERNAL CARE; MOLECULAR WEIGHT; NONHUMAN; PARASITE IDENTIFICATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOXOPLASMA GONDII;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN M; INFANT, NEWBORN; MOLECULAR WEIGHT; PREGNANCY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 84864543980     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00060-12     Document Type: Article

References (21)

1. Bénard A, et al. 2008. European Toxo Prevention Study Group (EUROTOXO). Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill. 13(15):18834. http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=18834.
2. Bessières MH, et al. 2009. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem. Inst. Oswaldo Cruz 104: 389-392.
3. Buffolano W, et al. 2005. Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis. J. Clin. Microbiol. 43:5916-5924. (Pubitemid 43100638)
4. Di Carlo P, Romano A, Schimmenti MG, Mazzola A, Titone L. 2008. Materno-foetal Toxoplasma gondii: critical review of available diagnostic methods. Infez. Med. 16:28-32. (Pubitemid 351518466)
5. Faucher B, et al. 2012. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children. J. Infect. 64:104. doi: 10.1016/j.jinf.2011.10.008.
6. Faucher B, Miermont F, Ranque S, Franck J, Piarroux R. 2012. Optimization of Toxoplasma gondii NA extraction from amniotic fluid using NucliSENS easyMAG and comparison with QIAampDNAminikit. Eur. J. Clin. Microbiol. Infect. Dis. 31:1035-1039.
7. Franck J, Mary C, Laugier M, Dumon H, Quilici M. 1990. Interest of Western blot technique in the diagnosis of congenital toxoplasmosis. Bull. Soc. Fr. Parasitol. 10:3-11. (In French.)
8. Franck J, Lanza-Silhol F, Vuillemot L, Pelissier V, Dumon H. 2000. Congenital toxoplasmosis diagnosis by immunoblot; a prospective study using a new commercial immunoblotting kit, abstract. In Niewiadomska K (ed), VIII European Multicolloquium of Parasitology. Witold Stefanski Institute of Parasitology, Warsaw, Poland.
9. Gilbert RE, et al. 2007. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J. Med. Screen. 14:8-13. (Pubitemid 46440359)
10. Gras L, et al. 2005. European Multicenter Study on Congenital Toxoplasmosis. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. 94:1721-1731. (Pubitemid 43155582)
11. Kieffer F, et al. 2008. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr. Infect. Dis. J. 27:27-32.
12. Machado AS, et al. 2010. IgG and IgM western blot assay for diagnosis of congenital toxoplasmosis. Mem. Inst. Oswaldo Cruz 105:757-761.
13. Magi B, Migliorini L. 2011. Western blotting for the diagnosis of congenital toxoplasmosis. New Microbiol. 34:93-95.
14. Montoya JG, Remington JS. 2008. Management of Toxoplasma gondii infection during pregnancy. Clin. Infect. Dis. 47:554-566.
15. Peyron F, et al. 2011. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr. Infect. Dis. J. 30:597-600.
16. Pinon JM, et al. 2001. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G,Mand A antibodies. J. Clin. Microbiol. 39:2267-2271. (Pubitemid 32531492)
17. Remington JS, Thulliez P, Montoya JG. 2004. Recent developments for diagnosis of toxoplasmosis. J. Clin. Microbiol. 42:941-945. (Pubitemid 38332808)
18. Robert-Gangneux F, et al. 2010. Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 29:33-38.
19. Tissot Dupont D, et al. 2003. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 22:122-125. (Pubitemid 36349977)
20. Villena I, et al. 1998. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand. J. Infect. Dis. 30:295-300. (Pubitemid 28461601)
21. Wallon M, et al. 2010. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet. Gynecol. 115:727-733.